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Abstract
Introduction: Malaria is the main cause of death by infection among travelers and is preventable through a combination of 
chemoprophylaxis and personal protective measures. Methods: Travelers were interviewed by phone 28–90 days after returning, 
to assess adherence to pre-travel advice for malaria prevention. Results: A total 57 travelers were included. Adherence to 
chemoprophylaxis was significantly higher among participants prescribed mefloquine (n=18; 75%) than doxycycline (n=14; 45%). 
Adherence to mosquito repellent and bed net use was 65% and 67%, respectively. Conclusions: Adherence to malaria prophylaxis 
was lower than expected. Further studies testing innovative approaches to motivate travelers’ compliance are required.
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An estimated 125 million travelers visit malaria-endemic 
areas every year, with 25,000 possibly acquiring the disease. Of 
these, 10,000 are reported and 150 are fatal1. The individual risk 
of acquiring malaria is influenced by host immune status, travel 
duration and destination, season, and use of preventive measures2. 
Malaria prevention relies on a combination of chemoprophylaxis 
and personal protective measures, such as insect repellent, 
insecticide-treated bed nets, and sleeping in air-conditioned 
rooms3. Chemoprophylactic drugs include chloroquine, 
doxycycline, mefloquine, primaquine, and atovaquone/proguanil. 
The choice relies on drug availability in the country, the traveler’s 
destination, medical history, and budget. 
To our knowledge, there are no data on adherence to malaria 
preventive measures among travelers departing from middle-
income countries like Brazil. Given that malaria and other 
mosquito-borne diseases are endemic in the country, travelers 
may have greater awareness about risks in similar settings, which 
could influence adherence to preventive recommendations.
Our study objective was to assess compliance of Brazilian 
travelers to malaria-prevention strategies, specifically regarding 
use of repellents, bed nets, and malaria chemoprophylaxis, as 
well as factors associated with non-adherence. 
Travelers who consulted the Travel Medicine Center of the 
Federal University of Rio de Janeiro (Cives) from April 2014 to 
November 2015 were invited to participate. Chemoprophylaxis 
prescriptions were tailored to travelers’ characteristics and 
planned trip.  Doxycycline is the only malaria chemoprophylactic 
drug marketed in Brazil, making it the only choice for many 
centers. Mefloquine was provided by the Pharmaceutical 
Laboratory of the Brazilian Army for this study and offered 
without cost to travelers. Travelers who used atovaquone/
proguanil bought it abroad before reaching malaria risk areas.
Returning travelers were contacted by phone 28–90 days after 
returning. Data collected included age, sex, marital status, travel 
route, and trip motivation and duration. Travelers were asked 
about their compliance with use of repellent, bed nets, and malaria 
chemoprophylaxis. Travelers who used malaria chemoprophylaxis 
were asked about the occurrence of adverse events. 
Adherence to malaria chemoprophylaxis was categorized 
as complete (no doses missed), missed <50% of doses, missed 
≥50% doses, stopped medication on return, and no doses taken. 
Similarly, adherence to repellents and bed nets was graded as 
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always adhered, adhered >50% of the time, adhered 25%–50% 
of the time, and <25% of the time. 
Categorical data variables are described as absolute counts 
and percentages. Quantitative variables are summarized as 
median and interquartile range (IQR). The distribution of 
categorical variables was compared using chi-square and 
Fisher’s exact tests. The Mann–Whitney test was used for 
quantitative variables.  For all analyses, significance was set 
at 0.05.
Among 85 travelers successfully contacted, 57 had visited 
malaria risk areas; these were included in the analyses. Median 
time between travel return and the interview was 48 days 
(IQR: 31–57 days).
Table 1 presents the general characteristics of included 
participants. Business was the main reason for travel. Pre-travel 
consultation occurred a median 24 days before travel, and 
median trip duration was 21 days. The most visited continent 
was Africa, especially sub-Saharan countries (68% of trips), 
followed by South America (25%) (Table 2). Domestic travel 
within Brazil (mainly the Amazon region) ranked second (15%) 
among all travel destinations. 
Most patients were prescribed doxycycline (n=31, 54%) or 
mefloquine (n=24, 42%). Atovaquone/proguanil was used by 
only two (4%) participants. 
Complete adherence to chemoprophylaxis was reported 
by 34 (60%) travelers; 1 (2%) traveler missed <50% of doses, 
12 (21%) missed ≥50%, 7 (12%) discontinued upon return, 
and 3 (5%) decided not to take any medication after pre-travel 
consultation. Complete adherence was significantly more 
frequent among travelers prescribed mefloquine (n=18; 75%) 
than those prescribed doxycycline (n=14; 45%; p=0.024). 
Among 54 travelers that started chemoprophylaxis, 10 (18%) 
reported adverse events. There was a non-significant trend 
toward higher incidence of adverse events among participants 
treated with mefloquine (n=6, 26%) than those treated with 
doxycycline (n=4; 14%; p=0.3). Adverse events associated 
with mefloquine were nightmares and vivid dreams (n=3), 
anxiety, depressed mood, and nausea (n=1 each). Adverse 
events reported with doxycycline were nausea (n=1), headache 
(n=1), and candidiasis (n=2). There was no association between 
adherence and occurrence of side effects (p=0.4). 
Full adherence to mosquito repellent was observed in 
37 (65%) travelers. Bed nets were recommended to 33 
travelers, with full adherence in 22 (67%). We found no 
significant association between complete adherence to malaria 
chemoprophylaxis and full compliance with repellent or bed 
net use (p=1.00).
Table 3 presents analysis results for factors associated 
with reported adherence to preventive measures. Adherence 
to malaria chemoprophylaxis was higher among travelers who 
stayed at hotels (p<0.01). Married travelers were more adherent 
to repellents (n=27; 79%; p=0.01) and bed nets (n=19; 83%; 
p=0.006). We also found a borderline significant association 
between traveling for leisure and lower adherence to bed net use 
(p=0.05). No other significant associations were found between 
TABLE 1: General characteristics of travelers in this study.
Characteristics n (%)
Travelers 57 (100)
Age (years) 40 (32–47)*
Female sex 31 (54) 
Marital status
   Married 34 (60)
   Single 23 (40)
Main motivation for consultation 
   Malaria prevention 21 (37)
   Others’ suggestion 13 (23)
   Vaccination 9 (16)
   Diseases in general 7 (12)
   Altitude illness prevention 2 (3)




Religious (missionaries) 15 (26)
Visiting friends and relatives   1 (2)
Accommodation
Hotel 28 (49)
Local residence 20 (35)
Hostel   1 (2)
Other 8 (14)
Travel insurance 49 (86)
Time between consultation and departure (days) 24 (12–41)*
Trip duration (days) 21 (13–32)*
* Median (interquartile range).
the studied covariates and adherence to preventive measures.
To offer better travel counseling, it is important to assess 
adherence, reasons for non-compliance, and the influence on 
risk of travel-related illnesses. Full adherence to preventive 
recommendations is an ideal but difficult goal that depends on 
aspects related both to the traveler and physician. In this study, 
we present data on adherence to preventive interventions used 
to avoid malaria infection among travelers departing from Rio 
de Janeiro, Brazil. As reported elsewhere, sub-Saharan Africa 
was the most frequent travel destination4. However, our center 
commonly advises travelers planning domestic trips within 
Brazil, mainly to the Amazon region, where malaria and 
yellow fever are major concerns. Malaria chemoprophylaxis 
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TABLE 2: Travel destinations of participants.
Destination n (% total)
Sub-Saharan Africa 39 (68)
Guinea-Bissau 17 (22)
South Africa   9 (12)
Tanzania   6 (8)
Senegal   4 (5)
Other  17 (22)
South America 14 (25)
Brazil (Amazon)   9 (12)
Brazil (other)   2 (3)
Other   4 (5) 
Southeast Asia and Pacific Islands   4 (7)
Indonesia   3 (4)
Myanmar   2 (3)
Vietnam   1 (1)
Cambodia   1 (1)
Malaysia   1 (1) 
Other   1 (1)
*Median (interquartile range).
is not usually recommended by the Brazilian Health Ministry5 
for travelers to the Amazon because Plasmodium vivax is the 
predominant etiologic agent in the region, and drugs frequently 
used for chemoprophylaxis do not act on the hypnozoites. 
Nonetheless, the risk of exposure to P. falciparum infection 
is unpredictable in some areas. Therefore, chemoprophylaxis 
may be indicated for travelers to areas with difficult access to 
medical assistance, trip duration longer than the incubation 
period of disease, or those presenting any health condition that 
could increase the risk of severe malaria5,6. 
Although the studied population lived in an endemic area 
for mosquito-borne infections and thus should be aware of the 
importance of preventing these diseases, compliance with the 
preventive recommendations was lower than expected. In fact, 
adherence to malaria chemoprophylaxis tended to be lower 
than adherence reported among travelers departing from high-
income countries4,7. This may be partly related to differences in 
the definition of complete adherence, which in our study was 
travelers reporting having taken a full course of the prescribed 
drug. Alternatively, our results might be influenced by the fact 
that doxycycline, the most frequently prescribed drug in this 
study, was associated with significantly lower compliance than 
mefloquine. This finding is in line with recommendations for 
the use of mefloquine as the first choice for chemoprophylaxis, 
after excluding any possible contraindications, in places where 
doxycycline is the only other alternative8. 
The lower adherence to doxycycline found in this study 
was apparently not related to a higher frequency of adverse 
events. In line with other reports9, we found no significant 
difference in the frequency of such events between patients 
treated with doxycycline and mefloquine. Others have reported 
that doxycycline is associated with more adverse effects that 
interfere with daily life than mefloquine8. This might explain 
the lower adherence to doxycycline, despite the absence of a 
significant difference in the frequency of adverse events in our 
study. Additionally, the lack of association between the rate of side 
effects and non-adherence could be, in many cases, a consequence 
of travelers’ beliefs and intentions. This should be considered 
during pre-travel consultation, to improve adherence10. 
Reported adherence to mosquito repellent use varies widely 
in the literature, ranging from 40% to 91%5,7,11. In some reports, 
the probability of adhering to repellents was higher among 
travelers who were compliant with chemoprophylaxis12. This 
association was not supported by our results. Insecticide-treated 
bed nets have been shown to reduce the malaria risk among 
residents of endemic areas13, and studies among travelers report 
adherence between 32% to 50%14,15. The intermediate level of 
compliance with bite-avoidance measures in this study suggests 
that travelers already living in an area endemic for mosquito-
borne infections are not more likely to adhere to repellent 
use, possibly because it is more difficult for these travelers to 
perceive risk in an environment that they find familiar.
4/5
TABLE 3: Analysis of factors associated with adherence to different preventive recommendations. 
Variable

















Sex 0.6               0.3 0.3
   Male 17 (65) 9 (35) 19 (73) 7 (27) 12 (80) 3 (20)
   Female 17 (55) 14 (45) 18 (58) 13 (42) 10 (56) 8 (44)
Age (years)* 43 (36-49) 43 (39-49) 0.8 43(37-48) 39 (38-56) 0.5 44 (39-49) 40 (35-44) 0.2
Marital status 1.0 0.01 0.006
    Single 14 (61) 9 (39) 10 (44) 13 (56) 3 (30) 7 (70)




   Malaria 
prevention
14 (67) 7 (33) 11 (52) 10 (48) 6 (50) 6 (50)
   Other 20 (56) 16 (44) 26 (72) 10 (28) 16 (76) 5 (24)
Reason for travel 0.8 0.1 0.05
   Business 13 (54) 11 (46) 14 (58) 10 (42) 8 (73) 3 (27)
   Missionary 9 (60) 6 (40) 13 (87) 2 (13) 12 (80) 3 (20)
   Leisure 11 (65) 6 (35) 10 (59) 7 (41) 2 (29) 5 (71)
Destination 0.2 0.4 0.6
  Sub-Saharan 
Africa
26 (67) 13 (33) 27 (69) 12 (31) 20 (69) 9 (31)
  Other 8 (44) 10 (56) 10 (56) 8 (44) 2 (50 ) 2 (50)
Accommodation 0.01 0.6 0.7
   Hotel 18 (82) 4 (18) 13 (59) 9 (41) 6 (60) 4 (40)




23 (18-41) 30 (19-36) 0.7 26 (19-34) 30 (20-56) 0.7 23 (16-37) 30 (20-37) 0.4
Trip duration 
(days)*
20 (17-31) 19 (10-33) 0.8 19 (11-33) 21 (19-25) 0.7 19 (10-33) 21 (19-25) 0.9
*Median (interquartile range).
Identification of predictors of low adherence to preventive 
measures may help to improve pre-travel counseling, to further 
raise awareness about the risk of malaria acquisition among 
travelers perceived to be at high risk for non-adherence. Our 
results suggest that travelers who are single, not staying in 
hotels, and traveling for leisure have increased risk of failing 
to comply with malaria preventive measures. 
This study has limitations such as its small sample and 
the fact that assessment of self-reported adherence may have 
overestimated the actual frequency. We also cannot rule out the 
possible influence of interannual variations in the characteristics 
of traveler groups. The large proportion of travelers belonging 
to a missionary group traveling to Guinea-Bissau might have 
introduced biases related to behavioral and cultural aspects. 
The suboptimal adherence to preventive measures observed 
in this and similar studies underlines the importance of further 
research assessing the predictors of non-compliance and 
testing innovative approaches to motivate traveler adherence 
to preventive recommendations.
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